By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for Tiapride
Email this page to a colleague
What is the drug development status for Tiapride?
Tiapride is an investigational drug.
There have been 5 clinical trials for Tiapride.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2012.
The most common disease conditions in clinical trials are Disease, Tourette Syndrome, and Schizophrenia. The leading clinical trial sponsors are Fundación Pública Andaluza Progreso y Salud, Instituto de Salud Carlos III, and Tasly Pharmaceuticals, Inc.
Summary for Tiapride
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,776 |
| WIPO Patent Applications | 622 |
| Japanese Patent Applications | 297 |
| Clinical Trial Progress | Phase 3 (2012-11-01) |
| Vendors | 32 |
Recent Clinical Trials for Tiapride
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacovigilance in Gerontopsychiatric Patients | Hannover Medical School | Phase 3 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis | Instituto de Salud Carlos III | Phase 3 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis | Fundación Pública Andaluza Progreso y Salud | Phase 3 |
Clinical Trial Summary for Tiapride
Top disease conditions for Tiapride
Top clinical trial sponsors for Tiapride
US Patents for Tiapride
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
